SAREPTA THERAPEUTICS INC - NOTE 1.250% 9/1

Historical Holders from Q3 2023 to Q3 2025

Type / Class
Debt / NOTE 1.250% 9/1
All holders as of 30 Sep 2025
Q3 2025
Total 13F principal, excl. options
423,204,030
Holdings value
$373,473,256
% of all portfolios
0%
Number of holders
30
Number of buys
12
Number of sells
-40
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of SAREPTA THERAPEUTICS INC - NOTE 1.250% 9/1

Period Principal Value Change Price Investors
2025 Q3 423,204,030 $373,473,256 -$483,579,314 $0.8797 30
2025 Q2 1,009,456,484 $771,135,004 -$30,695,954 $0.7338 57
2025 Q1 987,578,288 $920,780,195 +$32,593,408 $0.9316 75
2024 Q4 919,250,180 $1,045,725,240 -$29,748,516 $1.10 77
2024 Q3 935,735,828 $1,097,325,738 -$3,339,388 $1.14 72
2024 Q2 955,302,856 $1,269,526,221 -$95,435,668 $1.29 75
2024 Q1 1,029,532,211 $1,208,334,847 +$7,418,505 $1.17 63
2023 Q4 1,039,757,323 $1,059,310,870 +$23,391,526 $1.02 64
2023 Q3 1,003,179,309 $1,128,882,513 +$1,128,882,326 $1.12 64